載入...
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
There is an unmet medical need for anabolic treatments to restore lost bone. Human genetic bone disorders provide insight into bone regulatory processes. Sclerosteosis is a disease typified by high bone mass due to the loss of SOST expression. Sclerostin, the SOST gene protein product, competed with...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2003
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC291840/ https://ncbi.nlm.nih.gov/pubmed/14633986 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/emboj/cdg599 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|